Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 11.9 USD -0.5%
Market Cap: 328.2m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Clearpoint Neuro Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clearpoint Neuro Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Clearpoint Neuro Inc
NASDAQ:CLPT
Net Issuance of Debt
-$10m
CAGR 3-Years
16%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Issuance of Debt
$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Issuance of Debt
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Issuance of Debt
$2.4B
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Net Issuance of Debt
-$2.4B
CAGR 3-Years
-257%
CAGR 5-Years
12%
CAGR 10-Years
-18%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Clearpoint Neuro Inc
Glance View

Market Cap
328.3m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.91 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Clearpoint Neuro Inc's Net Issuance of Debt?
Net Issuance of Debt
-10m USD

Based on the financial report for Sep 30, 2024, Clearpoint Neuro Inc's Net Issuance of Debt amounts to -10m USD.

What is Clearpoint Neuro Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-36%

The average annual Net Issuance of Debt growth rates for Clearpoint Neuro Inc have been 16% over the past three years , -36% over the past five years .

Back to Top